Showing posts with label Covid19. Show all posts
Showing posts with label Covid19. Show all posts

Monday, May 25, 2020

NON INVASIVE PRENATAL TESTING (NIPT) MARKET GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST (2019 – 2027)

Meticulous Research®– leading global market research company published a research report titled “Non Invasive Prenatal Testing (NIPT) Market by Product & Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) – Global Forecast to 2027”. 
The high growth of non-invasive prenatal testing market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced and new technologies and non-invasive parenteral testing products, and improving reimbursement scenario for NIPT. In addition, rising awareness regarding non-invasive prenatal testing and untapped market opportunity in emerging markets offer significant growth opportunities for the players operating in this market.
Non-Invasive Prenatal Testing (NIPT), a novel genetic screening method based on the analysis of cell-free deoxyribose nucleic acid (cf-DNA) of the fetus in the maternal plasma is considered as a valuable test for the pregnant women to provide early diagnosis of genetic disorders. NIPT offers several advantages over conventional prenatal testing procedures; in addition to being non-invasive, these tests offer shorter turnaround times, lower risk to fetus and pregnant women during testing, and high accuracy. Increasing occurrences of chromosomal aneuploidies among fetus with the increase in maternal age, availability of the partial reimbursement policies for NIPT services in some of the countries, and developments in new technologies are the key factors driving steady growth in the global NIPT market.
Request Free Sample Report to get the short-term and long-term impact of COVID-19 on this Market https://www.meticulousresearch.com/request-sample-report/cp_id=5068
PNG-Non-Invasive-Prenatal-Testing-(NIPT)-Market---1
The global non-invasive prenatal testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027- by product & solution (consumables, systems, software), method (ultrasound screening, cell free DNA test), application (trisomy, microdeletions, monosomy), and end-user. The study also evaluates industry competitors and analyzes the market at regional and country level.
Click here to get the short-term and long-term impact of COVID-19 on this Market. https://www.meticulousresearch.com/enquire-before-buying/cp_id=5068
On the basis of products and solutions, the kits/consumables segment commanded the largest share of the overall NIPT market in 2019, mainly due to increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.
On the basis of application, trisomy segment accounted for the largest share of the overall NIPT market in 2019. The large share of this segment is mainly attributed to the factors such as the increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, diagnostic laboratories segment accounted for the largest share of the overall NIPT market in 2019, as the large volume of NIPT testing done at diagnostic laboratories owing to availability of the well-equipped facility and availability of trained/skilled laboratory technicians. The initiatives taken by diagnostic laboratories to provide high quality testing services is further driving the growth in this market.
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America commanded the largest share of the global non-invasive prenatal testing market in 2019, followed by Europe and Asia-Pacific regions. High diagnostic and treatment rate of trisomy disorders and the emergence of key organizations in the U.S. are accelerating the non-invasive prenatal testing market in the North American region.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5068
Key questions answered in the report-
  • Which are the high growth market segments in terms of product & solutions, method, application, end-users, and region/countries?
  • What was the historical market for non-invasive prenatal testing across the globe?
  • What are the market forecasts and estimates for the period 2019-2027?
  • What are the major drivers, restraints, opportunities, and trends in the global non-invasive prenatal testing market?
  • Who are the major players in the non-invasive prenatal testing market?
  • How is the competitive landscape and who are the market leaders in the global non-invasive prenatal testing market?
  • What are the different strategies adopted by the major players in the global non-invasive prenatal testing market?
  • What are the geographical trends and high growth regions/ countries?
Key Players
The key players operating in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (Massachusetts), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.) among others.
Request Free Sample Report to get the short-term and long-term impact of COVID-19 on this Market https://www.meticulousresearch.com/request-sample-report/cp_id=5068
Scope of the Report:
Non-Invasive Prenatal Testing Market by Product & Solutions
  • Kits / Consumables
  • Systems
    • Nuchal Translucency Ultrasound Devices
    • Next Generation Sequencing Systems
    • Microarrays
    • Polymerase Chain Reaction Instruments
  • Software
Market by Non-Invasive Prenatal Testing Method
  • Ultrasound Screening
  • Cell-free DNA Screening
Non-Invasive Prenatal Testing Market by Application
  • Trisomy Detection
  • Microdeletions Syndrome
  • Sex Chromosomal Abnormalities
  • Other Applications
Note: Other applications include sex determination and cystic fibrosis
Non-Invasive Prenatal Testing Market by End User
  • Diagnostic Laboratories
  • Hospitals
  • Academic and Research Institutes
Non-Invasive Prenatal Testing Market by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa                       ………..Continue
Download Sample Copy of Report, published in Feb 2020, with key industry insights spread across 191 pages, with 169 market data tables, 44 fig, including all graphs and charts @:  https://www.meticulousresearch.com/download-sample-report/cp_id=5068
Browse More Report of This Category at:
Urinalysis Market by Product (Pregnancy & Fertility Test, Dipstick, Reagent, Automatic, Semi-automatic, POC Analyzer), Application (Pregnancy, Diabetes, Kidney Disease, UTI), End-user (Hospitals and Clinics, Laboratory, Home Care) – Global Forecast to 2027
Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare) – Global Forecast to 2027
Healthcare Virtual Assistants Market by Product (Chatbot and Smart Speaker), Technology (Speech Recognition, Text-to-Speech, and Text Based), End User (Providers, Payers, and Other End User), and Geography–Global Forecast to 2025
Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography–Global Forecast to 2025
Contact Us:
Khushal
Meticulous Research®
Contact Sales- +1-646-781-8004
Email: sales@meticulousresearch.com
Website: https://www.meticulousresearch.com
Find us on: | LinkedIn | Twitter |

Tuesday, April 21, 2020

Impact of COVID-19 on Vaccines Market | Global Opportunity Analysis and Industry Forecast (2019-2027)

Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccines are biological agents that elicit an immune response against a specific antigen derived from the disease-causing pathogen. The development of vaccine has led to the eradication of various infectious diseases such as smallpox and polio, which are now completely eliminated from many countries, including countries located within North & Latin America and Europe. Further, with the advancements in vaccine production techniques and an increase in adoption, it is speculated that the other pandemic diseases will soon be eliminated like other diseases.

Vaccination is based on the principle of altering immunity by inducing the multiplication of specialized cells, mainly lymphocytes, which either kill virus-infected cells by direct contact or through proteins they secrete. The induced immune response against disease-causing organisms through vaccine configures the body’s immune cells in such a way so that they become capable of quickly recognizing and reacting to the same antigen in a more powerful manner when encountered again. Thus, due to the vaccine’s high potential in the prevention of diseases, the development of new vaccines is growing exponentially with incessant launch of new vaccines and many candidates in pipelines. According to the World Health Organization (WHO), as of September 2018, across all cases of infectious diseases, around 463 products are in pipeline. The top products in pipelines include vaccines 240 in number when compared to 138 as of May 2017 followed by diagnostics (93) and medicines (81). Similarly, according to Pharmaceutical Research and Manufacturers of America (PhRMA), in 2018, around 1,100 medicines and vaccines were in the development stage in the U.S. for cancer treatment as compared to 900 medicines and vaccines in 2012.

The global vaccines market is expected to growat a CAGR of 5.2% from 2019 to 2027 to reach $62.16 billion by 2027. The growth in this market is majorly driven by factors such as strong pipeline for vaccines, increasing government focus on immunization programs, and technological progress in vaccine administration. In addition, increasing epidemic potentials and growing focus on therapeutic vaccines, and growth prospects in emerging markets are expected to offer significant growth opportunities for the players operating in the vaccines market. However, the high cost associated with vaccine development and longer timelines for vaccine manufacturing hinders the growth of this market.

The global vaccines market studied in this report is segmented on the basis of indication (Pneumococcal disease, Influenza, Human Papilloma Virus (HPV), DTP, meningococcal disease, rotavirus, poliomyelitis, MMR, hepatitis, and others), route of administration (intramuscular, subcutaneous, oral, others), antigen type (subunit & conjugate, inactivated, live-attenuated, toxoid, combination), valence (multivalent, monovalent), and geography. 


On the basis of indication, the pneumococcal disease segment commanded the largest share of the global vaccines market in 2019. The major share of this segment is primarily attributed to the rising incidence of pneumococcal diseases like pneumonia, meningitis, febrile bacteraemia, otitis media, and sinusitis; the development of quality vaccines such as PPSV23; and initiatives by government organizations and private sectors to prevent and control the outbreak of pneumococcal diseases. Owing to these reasons, the demand for pneumococcal vaccines is consistently increasing globally, thereby driving the growth of this market.

To gain more insights into the market with a detailed table of content and figures, with free sample report, click here:  https://www.meticulousresearch.com/request-sample-report/cp_id=5076

Scope of the Report:
Global Vaccines Market, by Indication
  • Pneumococcal Disease
  • Influenza
  • DTP
  • Human Papilloma Virus (HPV)
  • Meningococcal Disease
  • Poliomyelitis (Polio)
  • MMR
  • Rotavirus
  • Hepatitis
  • Other Indications
    (Note: Other indications include varicella, herpes zoster vaccines, chlorella, and rabies vaccines.)
Global Vaccines Market, by Route of Administration
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Oral
  • Other Routes
    (Note: Other routes include intradermal (ID), transcutaneous (TC), and nasal route)
Global Vaccines Market, by Type/Antigen
  • Subunit & Conjugate Vaccines
  • Inactivated vaccines
  • Live Attenuated Vaccines
  • Toxoid vaccines
  • Combination Vaccines
Global Vaccines Market, by Valence
  • Multivalent Vaccines
  • Monovalent vaccines
Global Vaccines Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa ….Continue
Additional Insights-
In addition to global opportunity analysis and market forecasts, the Vaccines Market study provides detailed insights on regulatory analysis, product pipeline analysis, pricing analysis, and unmet need analysis. The study also showcases competitive benchmarking for top market players, by product and geography. The competitive landscape of this study also provides market share analysis, by market players and vaccines brand.
Some of the key players operating in the global vaccines market are Sanofi (France), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Daiichi Sankyo Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), and AstraZeneca (U.K.) among others.


Key questions answered in the report-
What is Vaccines Market?
 What are the market size forecasts and CAGR from the period 2019-2027?
 Which are the largest and fastest growing vaccine types of the market?
 What are the major drivers of the market?
 What are the major restraints of the global vaccines market?
 What are the major opportunities in the global market?
 What are the major challenges in the global market?
 Who are the major key players operating in the global vaccines market?
 What are high growth countries/regions in the market?

Download Free Sample Report for future analysis @ https://www.meticulousresearch.com/download-sample-report/cp_id=5076

Browse More Report of This Category at:

Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents and Assay), Technology, Application (Cardiac, Troponin, BNP) - Global Forecast to 2025
Real World Evidence Solutions Market by Component (RWD, EMR, Claim, Patient Registry, Pharmacy, Service), Application (Oncology, CVD, Neuro, Infection, Regulatory), End User (Pharma, Biotech, Medical Devices, Payers, Healthcare) - Global Forecast to 2024
Pharmaceutical Processing and Packaging Equipment Market by Mode of Drug Delivery (Oral, Parenteral, Topical), Secondary Packaging (Cartoning, Labeling), and End-Of-Line (Case Packaging, Palletizing, and Depalletizing) - Global Forecast to 2025